Implants

IMPLANET Reports Its 2023 Full-Year Results

Governance evolution in line with the agreement with Sanyou Medical BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP,…

9 months ago

Accelus President & CEO Kevin McGann to Present at LSI USA ’24 Conference

Accelus President & Chief Executive Officer Kevin McGann Kevin McGann, Accelus President & CEO, has been named to the company's…

9 months ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue…

9 months ago

Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

9 months ago

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results

LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…

9 months ago

Establishment Labs Announces Amended Credit Facility with Oaktree

- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…

9 months ago

Establishment Labs Announces Amended Credit Facility with Oaktree

- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®…

9 months ago

Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant

Received Notice of Allowance from the USPTO on February 15, 2024LOS GATOS, CA / ACCESSWIRE / February 22, 2024 /…

9 months ago

CORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock

Raises Approximately $2.6 Million in Gross ProceedsRetires $1.25 Million in Secured DebtThis corrects and replaces the headline in the release…

9 months ago

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter and full year ended…

9 months ago